Last reviewed · How we verify
AJU-C52L
At a glance
| Generic name | AJU-C52L |
|---|---|
| Also known as | Test Drug |
| Sponsor | AJU Pharm Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Efficacy and Safety of AJU-C52 in Essential Hypertension Patients (PHASE3)
- A Clinical Trial to Evaluate the Safety and Pharmacokinetics of AJU-C52L in Healthy Volunteers (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- AJU-C52L CI brief — competitive landscape report
- AJU-C52L updates RSS · CI watch RSS
- AJU Pharm Co., Ltd. portfolio CI